Literature DB >> 32441482

Fusobacterium nucleatum exacerbates colitis by damaging epithelial barrier and inducing aberrant inflammation.

Hua Liu1, Xialu Hong1, Tiantian Sun1, Xiaowen Huang1, Jilin Wang1, Hua Xiong1.   

Abstract

AIM: Recently, accumulating evidence has revealed strong association between intestinal microbiota alteration and inflammatory bowel disease (IBD). Fusobacterium (F.) nucleatum is a gram-negative anaerobe. A multicenter cohort study reported that F. nucleatum was enriched in newly diagnosed IBD patients. Here, we aimed to explore the pathogen of IBD and its pathogenic mechanism.
METHODS: Several bacteria associated with IBD or colorectal cancer were measured in fecal samples of 91 IBD patients and 43 healthy people. Mice with dextran sulfate sodium (DSS)-induced colitis and Caco-2 model system were used to explore the pathogenicity of F. nucleatum. Barrier damage was evaluated by transmission electron microscope, permeability of fluorescein isothiocyanate-dextran, transepithelial electrical-resistance and immunofluorescence. Protein level of cell-cell junction and activation of STAT3 signaling pathway were detected by immunohistochemistry and immunoblot. Cytokines secretion and T cell differentiation were measured by quantitative real-time polymerase chain reaction and flow cytometry.
RESULTS: F. nucleatum was significantly enriched in feces of IBD patients and its abundance was correlated with patients' disease activity. Administration of F. nucleatum markedly exacerbates colitis in DSS mice model. Mechanistically, F. nucleatum damaged epithelial integrity and increased permeability by regulating the expression and distribution of tight junction proteins ZO-1 and occludin. Moreover, F. nucleatum promoted secretion of cytokines (TNF-α, IFN-γ, IL-1β, IL-6, and IL-17), activated STAT3 signaling pathway, and induced proliferation of CD4+ T cell and differentiation of Th1 and Th17 subsets.
CONCLUSIONS: Our finding suggests that F. nucleatum could damage intestinal barrier and induce aberrant inflammation, which exacerbate colitis. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Fusobacterium nucleatum; colitis; inflammation; inflammatory bowel disease; intestinal barrier

Year:  2020        PMID: 32441482     DOI: 10.1111/1751-2980.12909

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  18 in total

Review 1.  FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence.

Authors:  Catarina D Simões; Marta Maganinho; Ana S Sousa
Journal:  Eur J Nutr       Date:  2022-01-06       Impact factor: 5.614

Review 2.  The role of oral bacteria in inflammatory bowel disease.

Authors:  Emily Read; Michael A Curtis; Joana F Neves
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-16       Impact factor: 46.802

3.  Periodontitis may induce gut microbiota dysbiosis via salivary microbiota.

Authors:  Jun Bao; Lili Li; Yangheng Zhang; Min Wang; Faming Chen; Shaohua Ge; Bin Chen; Fuhua Yan
Journal:  Int J Oral Sci       Date:  2022-06-23       Impact factor: 24.897

Review 4.  Loss of Gut Barrier Integrity In Lupus.

Authors:  Longhuan Ma; Laurence Morel
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 5.  Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.

Authors:  Yusuke Kinashi; Koji Hase
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

Review 6.  Periodontal connection with intestinal inflammation: Microbiological and immunological mechanisms.

Authors:  Sho Kitamoto; Nobuhiko Kamada
Journal:  Periodontol 2000       Date:  2022-03-04       Impact factor: 12.239

7.  Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.

Authors:  Cody A Despins; Scott D Brown; Avery V Robinson; Andrew J Mungall; Emma Allen-Vercoe; Robert A Holt
Journal:  mBio       Date:  2021-10-26       Impact factor: 7.867

Review 8.  Oral microbiota in human systematic diseases.

Authors:  Xian Peng; Lei Cheng; Yong You; Chengwei Tang; Biao Ren; Yuqing Li; Xin Xu; Xuedong Zhou
Journal:  Int J Oral Sci       Date:  2022-03-02       Impact factor: 24.897

Review 9.  Bacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms.

Authors:  Li Zhang; Fang Liu; Jessica Xue; Seul A Lee; Lu Liu; Stephen M Riordan
Journal:  Front Microbiol       Date:  2022-02-24       Impact factor: 5.640

Review 10.  The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases.

Authors:  Valerio Baldelli; Franco Scaldaferri; Lorenza Putignani; Federica Del Chierico
Journal:  Microorganisms       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.